Croda International PLC (LON:CRDA) Stock “Buy” Rating Reconfirmed at Berenberg; The Target Price per Share is Set to GBX 5050.00; Uss Investment Management LTD Has Decreased By $1.95 Million Its Merck & Co (MRK) Position

In a research report shared with investors and clients on Thursday morning, Croda International PLC (LON:CRDA) stock “Buy” was kept by Analysts at Berenberg. They currently have a GBX 5050.00 PT on the stock. Berenberg’s PT gives a potential upside of 10.23% from the company’s last price.

Uss Investment Management Ltd decreased Merck & Co Inc (MRK) stake by 3.98% reported in 2017Q3 SEC filing. Uss Investment Management Ltd sold 30,500 shares as Merck & Co Inc (MRK)’s stock declined 2.46%. The Uss Investment Management Ltd holds 735,500 shares with $47.09 million value, down from 766,000 last quarter. Merck & Co Inc now has $147.72 billion valuation. The stock decreased 0.91% or $0.5 during the last trading session, reaching $54.22. About 11.27M shares traded. Merck & Co., Inc. (NYSE:MRK) has risen 16.86% since March 1, 2017 and is uptrending. It has outperformed by 0.16% the S&P500.

Investors sentiment increased to 1.43 in Q3 2017. Its up 0.39, from 1.04 in 2017Q2. It increased, as 5 investors sold Croda International plc shares while 18 reduced holdings. 9 funds opened positions while 24 raised stakes. 8.83 million shares or 3.31% less from 9.14 million shares in 2017Q2 were reported. California State Teachers Retirement System invested in 19,610 shares or 0% of the stock. 84,565 are held by Parametric Assocs Limited. Alliancebernstein Ltd Partnership holds 0% or 15,400 shares in its portfolio. Dimensional Fund Lp has 0% invested in Croda International plc (LON:CRDA). Axa owns 201,800 shares. Brant Point Inv Mngmt Ltd Liability Corporation holds 80,000 shares or 0.1% of its portfolio. The California-based Globeflex L P has invested 0.09% in Croda International plc (LON:CRDA). Nationwide Fund Advsrs reported 7,399 shares. 77,260 are owned by Cornercap Invest Counsel Inc. Parallax Volatility Advisers Ltd Partnership stated it has 534 shares or 0% of all its holdings. Zebra Management Limited Liability Corporation stated it has 0.04% in Croda International plc (LON:CRDA). Cambridge Invest Research reported 62,701 shares. First Quadrant Lp Ca reported 3,300 shares. Gsa Capital Prns Ltd Liability Partnership has 85,232 shares. State Board Of Administration Of Florida Retirement Sys owns 28,535 shares.

Among 21 analysts covering Croda International PLC (LON:CRDA), 8 have Buy rating, 2 Sell and 11 Hold. Therefore 38% are positive. Croda International PLC has GBX 5050 highest and GBX 2350 lowest target. GBX 3916.33’s average target is -14.92% below currents GBX 4603 stock price. Croda International PLC had 153 analyst reports since July 23, 2015 according to SRatingsIntel. The rating was maintained by Numis Securities on Tuesday, July 5 with “Hold”. UBS maintained the shares of CRDA in report on Monday, November 16 with “Sell” rating. The stock has “Overwt/In-Line” rating by Morgan Stanley on Tuesday, February 23. The firm earned “Neutral” rating on Wednesday, December 2 by JP Morgan. Numis Securities maintained it with “Hold” rating and GBX 3419 target in Monday, August 1 report. Deutsche Bank maintained the stock with “Hold” rating in Wednesday, March 1 report. The stock of Croda International plc (LON:CRDA) has “Buy” rating given on Wednesday, February 24 by Deutsche Bank. On Wednesday, November 30 the stock rating was downgraded by Deutsche Bank to “Buy”. The firm has “Overweight” rating given on Tuesday, January 9 by Barclays Capital. Deutsche Bank maintained the stock with “Hold” rating in Friday, March 31 report.

The stock decreased 0.41% or GBX 19 during the last trading session, reaching GBX 4603. About 33,815 shares traded. Croda International plc (LON:CRDA) has 0.00% since March 1, 2017 and is . It has underperformed by 16.70% the S&P500.

Croda International Plc creates, makes, and sells specialty chemicals in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company has market cap of 6.00 billion GBP. It offers adhesives; crop protection additives and adjuvants, speciality additives for agricultural films, and seed enhancement and animal health chemicals; lubricant additives, speciality additives for plastics, coatings and polymers, advanced materials, and vehicle cleaning chemicals; and specialty ingredients for skin care, hair care, sun care, self-tanning, color cosmetics, body care, bath and shower, deodorants, anti-perspirants, depilatories, men's grooming, oral hygiene, and baby care applications. It has a 28.64 P/E ratio. The firm also provides bio based phase change materials for building and construction markets; dietary supplements; electronics comprising phase change materials, advanced materials, and polymer additives; chemistries, emulsifiers, fuel and power generation additives, and polymer additives for energy and resource industries; food additives; speciality polymer additives for furniture and wood applications; household, industrial, and institutional cleaning products; lubricants; oleochemicals; industrial chemicals for packaging, print, and paper industries; paints and coatings; active pharmaceutical ingredients for treating illness and diseases; thermal management products; and plastic and rubber products for food packaging, carrier bags and toys, car bumpers, mobile phones, and home appliances.

Investors sentiment decreased to 1.06 in 2017 Q3. Its down 0.01, from 1.07 in 2017Q2. It dived, as 46 investors sold MRK shares while 619 reduced holdings. 106 funds opened positions while 598 raised stakes. 1.96 billion shares or 0.47% more from 1.95 billion shares in 2017Q2 were reported. Verity And Verity Ltd Liability Company accumulated 3,201 shares. Sumitomo Mitsui Tru Holding Inc reported 0.72% of its portfolio in Merck & Co., Inc. (NYSE:MRK). Beech Hill, New York-based fund reported 69,548 shares. Bancshares Of Hawaii reported 132,559 shares. Ontario Teachers Pension Plan Board has 157,513 shares. Nationwide Fund Advsr holds 1.82M shares or 0.46% of its portfolio. Columbus Hill Capital LP owns 695,172 shares or 3.17% of their US portfolio. Optimum has invested 0.33% in Merck & Co., Inc. (NYSE:MRK). Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Investment Mngmt Corp stated it has 0.15% in Merck & Co., Inc. (NYSE:MRK). 39,913 were reported by Cape Cod Five Cents Retail Bank. Boyd Watterson Asset Ltd Liability Com Oh invested 0.83% of its portfolio in Merck & Co., Inc. (NYSE:MRK). 66,805 were reported by First Allied Advisory Svcs Inc. Mcf Limited Liability Corporation stated it has 0.12% of its portfolio in Merck & Co., Inc. (NYSE:MRK). 3,821 are owned by Eubel Brady & Suttman Asset Management Inc. Cubic Asset Mngmt Limited Liability Corporation stated it has 0.24% in Merck & Co., Inc. (NYSE:MRK).

Among 24 analysts covering Merck & Co. Inc. (NYSE:MRK), 17 have Buy rating, 0 Sell and 7 Hold. Therefore 71% are positive. Merck & Co. Inc. has $7400 highest and $50 lowest target. $65.28’s average target is 20.40% above currents $54.22 stock price. Merck & Co. Inc. had 79 analyst reports since August 13, 2015 according to SRatingsIntel. BMO Capital Markets maintained the stock with “Buy” rating in Monday, June 12 report. The rating was maintained by Credit Suisse with “Neutral” on Monday, May 9. The firm has “Buy” rating by Guggenheim given on Thursday, January 12. On Tuesday, August 18 the stock rating was upgraded by BNP Paribas to “Outperform”. Jefferies maintained the shares of MRK in report on Friday, April 15 with “Hold” rating. Morgan Stanley maintained Merck & Co., Inc. (NYSE:MRK) rating on Wednesday, February 7. Morgan Stanley has “Equal-Weight” rating and $63 target. The firm has “Outperform” rating by BMO Capital Markets given on Tuesday, October 31. The stock of Merck & Co., Inc. (NYSE:MRK) has “Buy” rating given on Monday, October 30 by UBS. Jefferies maintained the shares of MRK in report on Thursday, July 14 with “Hold” rating. The stock of Merck & Co., Inc. (NYSE:MRK) has “Market Perform” rating given on Monday, October 23 by Leerink Swann.

Analysts await Merck & Co., Inc. (NYSE:MRK) to report earnings on May, 1. They expect $0.98 EPS, up 11.36% or $0.10 from last year’s $0.88 per share. MRK’s profit will be $2.67B for 13.83 P/E if the $0.98 EPS becomes a reality. After $0.98 actual EPS reported by Merck & Co., Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Uss Investment Management Ltd increased Cdw Corp (NASDAQ:CDW) stake by 210,000 shares to 1.55M valued at $102.10 million in 2017Q3. It also upped Southern Co (NYSE:SO) stake by 25,800 shares and now owns 151,729 shares. Cdn Imperial Bk Comm Toronto (NYSE:CM) was raised too.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: